Concepedia

Stewart Kroll

SK

46

Publications

5.1K

Citations

32

H-Index

1988

Active since

Affiliations

University of California, San Francisco(Current)

Corixa Corporation

Lawrence Berkeley National Laboratory

Cornell University

Threshold Pharmaceuticals (United States)

Stewart Kroll is an author at University of California, San Francisco specializing in medicine, radiation oncology, and oncology.

Top concepts

Publications per year

1988–2012

46

Publications

46

<sup>131</sup>I-Tositumomab Therapy as Initial Treatment for Follicular Lymphoma

Mark Kaminski, Melissa Tuck, Judith Estes et al. · New England Journal of Medicine · 2005 · 714 citations · Full text

Radioimmunotherapy with iodine 131I tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: updated results and long-term follow-up of the University of Michigan experience

Mark Kaminski, Judith Estes, Kenneth Zasadny et al. · Blood · 2000 · 521 citations

A phase I dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors

Luis E. Raez, Kyriakos P. Papadopoulos, Alejandro D. Ricart et al. · Cancer Chemotherapy and Pharmacology · 2012 · 509 citations

, , +8

Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors.

Mack Roach, David R. Gandara, Hae Sook Yuo et al. · Journal of Clinical Oncology · 1995 · 267 citations

Efficacy and Safety of Tositumomab and Iodine-131 Tositumomab (Bexxar) in B-Cell Lymphoma, Progressive After Rituximab

Sandra J. Horning, Anas Younes, Vinay Jain et al. · Journal of Clinical Oncology · 2004 · 259 citations

Rows per page

1–5 of 46